Inappropriate drug use in US nursing homes

2002 ◽  
Vol 349 (1) ◽  
pp. 7-7
2005 ◽  
Vol 39 (3) ◽  
pp. 405-411 ◽  
Author(s):  
Matthew Perri ◽  
Ajit M Menon ◽  
Aparna D Deshpande ◽  
Shashank B Shinde ◽  
Rong Jiang ◽  
...  

BACKGROUND: Little empirical evidence exists regarding the influence and outcomes of inappropriate medication use among elderly nursing home residents. OBJECTIVE: To identify the prevalence of inappropriate medication use among elderly patients in Georgia nursing homes using the Beers criteria and identify the relationship between inappropriate drug use and the likelihood of an adverse health outcome. METHODS: A cohort design was used to review 1117 patient medical records in 15 Georgia nursing homes with a high risk of polypharmacy. Prevalence of inappropriate medication use among elderly patients, as defined by the Beers criteria, was estimated. The adverse health outcomes of hospitalizations, emergency department visits, or deaths were identified from Medicaid claims data. RESULTS: A total of 519 (46.5%) patients received at least one inappropriate medication and 143 (12.8%) patients experienced at least one adverse health outcome. Logistic regression revealed that the total number of medications taken (OR 1.139, 95% CI 1.105 to 1.173) significantly increased the likelihood of receiving an inappropriate drug, while having a diagnosis of “dementia” (OR 0.748, 95% CI 0.565 to 0.991) decreased the likelihood. Inappropriate medication use increased the likelihood of experiencing at least one adverse health outcome more than twofold (OR 2.34, 95% CI 1.61 to 3.40). Propoxyphene use alone was significantly associated with the occurrence of an adverse health outcome (OR 2.39, 95% CI 1.54 to 3.71). CONCLUSIONS: Inappropriate drug use was common in our study cohort. Inappropriate use of medication in the elderly, particularly propoxyphene, is associated with a higher risk of adverse health outcomes.


Medical Care ◽  
2006 ◽  
Vol 44 (8) ◽  
pp. 722-730 ◽  
Author(s):  
Ilene H. Zuckerman ◽  
Patricia Langenberg ◽  
Mona Baumgarten ◽  
Denise Orwig ◽  
Patricia J. Byrns ◽  
...  

2005 ◽  
Vol 61 (5-6) ◽  
pp. 453-459 ◽  
Author(s):  
Graziano Onder ◽  
Francesco Landi ◽  
Rosa Liperoti ◽  
Daniela Fialova ◽  
Giovanni Gambassi ◽  
...  

2013 ◽  
Vol 20 (Suppl 1) ◽  
pp. A39.1-A39 ◽  
Author(s):  
LD Jensen ◽  
M Hallin ◽  
O Andersen ◽  
J Petersen

Drugs & Aging ◽  
2019 ◽  
Vol 37 (2) ◽  
pp. 115-123 ◽  
Author(s):  
Linda G. M. Mulder-Wildemors ◽  
Mette Heringa ◽  
Annemieke Floor-Schreudering ◽  
Paul A. F. Jansen ◽  
Marcel L. Bouvy

Drugs & Aging ◽  
2005 ◽  
Vol 22 (1) ◽  
pp. 69-82 ◽  
Author(s):  
Inga Klarin ◽  
Anders Wimo ◽  
Johan Fastbom

2009 ◽  
Vol 43 (7-8) ◽  
pp. 1233-1238 ◽  
Author(s):  
Kristina Johnell ◽  
Gunilla Ringbäck Weitoft ◽  
Johan Fastbom

Sign in / Sign up

Export Citation Format

Share Document